Home/Filings/4/0001213900-11-001155
4//SEC Filing

Bernstein Jeffrey L. 4

Accession 0001213900-11-001155

CIK 0001402479other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 2:45 PM ET

Size

4.9 KB

Accession

0001213900-11-001155

Insider Transaction Report

Form 4
Period: 2011-02-25
Bernstein Jeffrey L.
DirectorCEO and President
Transactions
  • Other

    Common Stock

    2011-02-25+3,000,0003,000,000 total
Footnotes (1)
  • [F1]In connection with a change of control in the Company, the Company's former chief executive officer transferred 3,000,000 shares of the Company to Mr. Bernstein, the Company's new chief executive officer.

Issuer

Atlas Therapeutics Corp

CIK 0001402479

Entity typeother

Related Parties

1
  • filerCIK 0001514502

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 2:45 PM ET
Size
4.9 KB